1-4 of 4
Geir Tjønnfjord
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Highly Restricted Usage of Immunoglobulin Light Chain IGKV3-20 with Stereotyped Sequence in Primary Cold-Agglutinin Disease (CAD)

Agnieszka Malecka, Gunhild Trøen, PhD, Anne Tierens, MD PhD, Ingunn Østlie, Ulla Randen, MD PhD, Sigbjorn Berentsen, MDPhD, Geir Tjønnfjord, MD PhD, Jan M.A. Delabie, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4137.
https://doi.org/10.1182/blood.V126.23.4137.4137
Published: 2015
Journal Articles

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL

Clinical Trials & Observations
Christian H. Geisler, Mars B. van t’ Veer, Jesper Jurlander, Jan Walewski, Geir Tjønnfjord, Maija Itälä Remes, Eva Kimby, Tomas Kozak, Aaron Polliack, Ka Lung Wu, Shulamiet Wittebol, Martine C. J. Abrahamse-Testroote, Jeanette Doorduijn, Wendimagegn Ghidey Alemayehu, Marinus H. J. van Oers
Journal: Blood
Blood (2014) 123 (21): 3255–3262.
https://doi.org/10.1182/blood-2014-01-547737
Published: 2014
Includes: Supplemental data
Journal Articles

Immunochemotherapy with Low-Dose Subcutaneous Alemtuzumab (A) Plus Oral Fludarabine and Cyclophosphamide (FC) Is Safe and Induces More and Deeper Complete Remissions in Untreated Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) Than Chemotherapy with FC Alone. An Early Analysis of the Randomized Phase-III HOVON68 CLL Trial

Christian H Geisler, MD, PhD, Mars MB van 't Veer, MD, PhD, Wim van Putten, MSc, Jesper Jurlander, MD.PHD, Jan Walewski, MD, PhD, Geir Tjonnfjord, MD, PHD, Maija Itälä-Remes, MD, PHD, Eva Kimby, M.D., Ph.D., Tomas Kozak, MD, PhD, Aaron Polliack, MD, Shulamiet Wittebol, MD, Fokje Spoelstra, PhD, Marinus H.J. Van Oers, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 290.
https://doi.org/10.1182/blood.V118.21.290.290
Published: 2011
Journal Articles

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome

Clinical Trials & Observations
Jeanette Lundin, Hans Hagberg, Roland Repp, Eva Cavallin-Ståhl, Susanne Fredén, Gunnar Juliusson, Eija Rosenblad, Geir Tjønnfjord, Tom Wiklund, Anders Österborg
Journal: Blood
Blood (2003) 101 (11): 4267–4272.
https://doi.org/10.1182/blood-2002-09-2802
Published: 2003